You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkin lymphoma (HL)

Showing 1 - 25 of 6,893
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

Active, not recruiting
  • Hodgkin Lymphoma Survivor
  • Clinical Assessment
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 22, 2022

Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)

Active, not recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • Valhalla, New York
    New York Medical College
Oct 24, 2022

Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 13, 2023

Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma Trial (AFM13, AB-101, Cyclophosphamide)

Not yet recruiting
  • Relapsed or Refractory Hodgkin Lymphoma
  • Peripheral T Cell Lymphoma
  • (no location specified)
May 30, 2023

Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

Recruiting
  • Lymphoma
  • +7 more
  • ATLCAR.CD30 cells
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

Hodgkin Lymphoma Trial in Canada, United States (doxorubicin, Bleomycin, vinblastine)

Recruiting
  • Hodgkin Lymphoma
  • Detroit, Michigan
  • +9 more
Feb 16, 2022

Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated

Completed
  • Hodgkin's Lymphoma
  • Cardiac Magnetic Resonance Imaging
  • Echocardiogram
  • Jacksonville, Florida
    University of Florida Health Proton Therapy Institute
Jun 9, 2022

Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma Trial in Seoul

Completed
  • Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
    • Seoul, Gangnam-Gu, Korea, Republic of
      Samsung Medical Center
    Feb 4, 2022

    Hodgkin Lymphoma, Adult Trial in United States (Brentuximab vedotin, ABVD)

    Completed
    Has Results
    • Hodgkin Lymphoma, Adult
    • Brentuximab vedotin
    • ABVD
    • Duarte, California
    • +5 more
    Nov 8, 2021

    Hodgkin Lymphoma Trial in Belgium, Denmark, Netherlands (gemcitabine, cisplatin and tislelizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • gemcitabine, cisplatin and tislelizumab
    • Brussels, Belgium
    • +14 more
    Aug 12, 2022

    Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

    Active, not recruiting
    • Recurrent Hodgkin Lymphoma
    • Refractory Hodgkin Lymphoma
    • Duarte, California
    • +3 more
    Oct 24, 2022

    Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic Trial in China (Brentuximab Vedotin)

    Completed
    Has Results
    • Hodgkin Disease
    • Lymphoma, Large-Cell, Anaplastic
    • Brentuximab Vedotin
    • Beijing, Beijing, China
    • +6 more
    Feb 3, 2021

    A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

    Recruiting
    • Hodgkin Lymphoma
    • No Intervention
    • Wroclaw, Dolnoslskie, Poland
    • +14 more
    Jun 23, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Hodgkin Lymphoma Trial in New York (Decitabine and

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +5 more
    • Decitabine and Cedazuridine
    • Nivolumab
    • New York, New York
      NY011 Laura and Isaac Perlmutter Cancer Center at NYU Langone
    Jul 8, 2022

    Hodgkin Lymphoma Trial in Italy (Doxorubicin, Bleomycin, Vinblastine)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Alessandria, Italy
    • +45 more
    Dec 22, 2022

    Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Caba (Evaluation of

    Recruiting
    • Hodgkin Lymphoma, Adult
    • +2 more
    • Evaluation of therapeutical approach after ASCT
    • Caba, Argentina
      FUNDALEU
    Oct 1, 2021

    Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular

    Recruiting
    • Ann Arbor Stage I Hodgkin Lymphoma
    • +13 more
    • Birmingham, Alabama
    • +16 more
    Nov 23, 2021

    Circulating Tumor DNA Genotyping for Biological Monitoring of

    Active, not recruiting
    • Hodgkin Lymphoma
      • Avellino, Italy
      • +12 more
      Dec 22, 2022

      Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory

      Active, not recruiting
      • Peripheral T Cell Lymphoma
      • Pediatric Hodgkin Lymphoma
      • Brentuximab Vedotin (Genetical Recombination)
      • Tokyo, Japan
        Takeda Selected Site
      Oct 11, 2022

      Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

      Recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Brentuximab Vedotin 50 MG [Adcetris]
      • Leon, Guanajuato, Mexico
        Hospital Regional Alta Especialidad Bajio
      Oct 24, 2022

      Hodgkin Lymphoma Trial in Italy (Brentuximab Vedotin)

      Completed
      • Hodgkin Lymphoma
      • Brentuximab Vedotin
      • Brescia, BS, Italy
      • +5 more
      Dec 21, 2020

      Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)

      Recruiting
      • Hodgkin's Lymphoma
      • Bydgoszcz, Poland
      • +12 more
      Dec 23, 2021

      Hodgkin's Lymphoma Trial in Houston (Azacytidine, Pembrolizumab)

      Recruiting
      • Hodgkin's Lymphoma
      • Houston, Texas
        MD Anderson Cancer Center
      Oct 5, 2022

      Hodgkin Lymphoma Trial in Italy (Tislelizumab)

      Not yet recruiting
      • Hodgkin Lymphoma
      • Alessandria, IT, Italy
      • +9 more
      Aug 4, 2023